Hepcidin After Intravenous Iron Treatment

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

NCT04968379 ·Status: WITHDRAWN ·Phase: PHASE2

The Purpose of the Study is to Examine Whether Iron Deficiency Anemia is Associated With Increased Production of Thrombin and Whether Correction of Anemia by Providing Iron Intravenously Causes a Significant Reduction in Production of Thrombin.

NCT02129907 ·Status: COMPLETED

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

NCT00395993 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

NCT04269707 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women

NCT04636060 ·Status: COMPLETED ·Phase: NA

Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.

NCT07110935 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.

NCT05217836 ·Status: UNKNOWN

Methemoglobinemia Following Intravenous Iron Treatment

NCT06309641 ·Status: COMPLETED

Different Iron Supplements for Prevention of Anemia in Pregnancy

NCT02487719 ·Status: UNKNOWN ·Phase: PHASE4

Hepcidin in Anemic Chronic Heart Failure (CHF) Patients

NCT00437866 ·Status: COMPLETED

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

NCT04205266 ·Status: RECRUITING ·Phase: PHASE4

Anemia and Inflammation

NCT03618914 ·Status: COMPLETED

Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women

NCT02683369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ferritin as a Predictor for Anemia in Pregnancy

NCT03565198 ·Status: UNKNOWN

Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure

NCT01925703 ·Status: COMPLETED ·Phase: PHASE4

IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department

NCT05153278 ·Status: COMPLETED

To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy

NCT02441439 ·Status: WITHDRAWN ·Phase: NA

Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone

NCT00000588 ·Status: COMPLETED ·Phase: PHASE2

Hypoferritinemia Without Anemia Among Reproductive Age Females

NCT06437080 ·Status: COMPLETED ·Phase: NA

Oral Iron Supplementation in Pulmonary Hypertension

NCT01446848 ·Status: COMPLETED ·Phase: NA

Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.

NCT01949467 ·Status: COMPLETED ·Phase: PHASE2

Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy

NCT01588665 ·Status: COMPLETED

Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia

NCT01309659 ·Status: TERMINATED ·Phase: PHASE2

Investigation of the Wash-out Effect of Intravenous Iron by Cell Savers (WASH-OUT)

NCT04631679 ·Status: COMPLETED

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

NCT00548860 ·Status: COMPLETED ·Phase: PHASE3